Home/ Supplements/ Ginkgo/ Ginkgo Biloba

Ginkgo Biloba

product on market Tablet or Pill Biotics Research Corporation Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Ginkgo biloba is supported by moderate evidence for cognitive support and circulatory health. Superoxide dismutase and catalase function as antioxidant enzymes to neutralize free radicals. Overall, clinical evidence for this specific ingredient combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Ginkgo Biloba
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Other Combinations
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 120.0mg (440 products) 191 studies (A:1, B:71)
Superoxide Dismutase
15 mcg
Catalase
15 mcg

Other Ingredients

Cellulose Stearic Acid Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

RECOMMENDATION: One (1) tablet one (1) to three (3) times each day as a dietary supplement or as otherwise directed by a healthcare professional.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN

Sealed with an imprinted safety seal for your protection.

Additional Information

Store in a cool, dry area.

Rev. 11/05

Specially grown, biologically active containing naturally associated and/or organically bound phytochemicals including polyphenolic compounds with SOD and catalase, dehydrated at low temperature to preserve associated enzyme factors.

Metadata

Product Details

DSLD Entry Date2013-05-24
Product TypeOther Combinations
FormTablet or Pill
DSLD ID21823
Data Updated2026-04-11
Research

Research Evidence

183
Research Sources
55
Avg Quality
86
Systematic Review
78
Meta Analysis
7
Other
4
Clinical Trial
2
Rct
2
Narrative Review
2
Regulatory Source
1
Openfda Safety
A Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Ginkgo biloba for cognitive impairment and dementia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Ginkgo biloba for tinnitus
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B Ginkgo biloba for tinnitus
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
B Ginkgo biloba for prevention of dementia: a randomized controlled trial
Rct JAMA 2008 PubMed DOI
B Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis
Systematic Review Frontiers in aging neuroscience 2023 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
B The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis
Systematic Review Frontiers in aging neuroscience 2020 PubMed DOI
B Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis
Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2026 PubMed DOI
B Ginkgo biloba for intermittent claudication
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
View all evidence for Ginkgo →
Compare

Similar Products

View all Ginkgo products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.